Urine Nandrolone Metabolites: False Positive Doping Test? R M N Kohler, M I Lambert

Total Page:16

File Type:pdf, Size:1020Kb

Urine Nandrolone Metabolites: False Positive Doping Test? R M N Kohler, M I Lambert 325 REVIEW Urine nandrolone metabolites: false positive doping test? R M N Kohler, M I Lambert ............................................................................................................................. Br J Sports Med 2002;36:325–329 The aim of this review is to analyse the studies on Recently, the possibility of false positive tests for nandrolone metabolism to determine if it is possible for nandrolone has been raised. Explanations for false positive tests have included supplement an athlete to test positive for nandrolone without having contamination18 and endogenous production of ingested or injected nandrolone. nandrolone and regulation of metabolic pathways .......................................................................... of nandrolone metabolism by various physiologi- cal factors and supplement interventions. The aim of this review is to analyse the studies on he anabolic androgenic steroid 19- nandrolone metabolism with the overall goal of nortestosterone, also called nandrolone, was determining whether it is indeed possible for an Tfirst synthesised by Birch in 1950.1 Nan- athlete to test positive for nandrolone without drolone has an anabolic effect, and is used in the having either ingested or injected nandrolone. treatment of certain chronic diseases.1–3 The use of The question of a positive test resulting from nandrolone by athletes became popular in the late nutritional supplements14 18 and food 1950s.4 Athletes use nandrolone in an oral or contamination19 20 is beyond the scope of this injectable form to increase muscle strength and review. improve performance.5 As a result of the potential performance enhancing benefits6 and potential EVIDENCE FOR ENDOGENOUS NA health risks associated with anabolic steroid use,7 The origin of endogenous NA in the urine of ath- the International Olympic Committee (IOC) pro- letes who have not knowingly ingested or injected hibited the use of nandrolone in sport in 1976. nandrolone is central to resolving the question of whether it is possible to have a false positive test. The first study to suggest that NA could be found “A doping offence for nandrolone was in the urine of people free of exogenous defined as a concentration of NA in human nandrolone was a study on laboratory staff (n = urine exceeding 2 ng/ml in men and 5 14).8 Their urine was analysed using isotope dilu- ng/ml in women” tion mass spectrometry, and NA or a similar com- pound was suspected. This suspicion was based When nandrolone is ingested or injected by on the detection of a small peak for the ion at m/z 8 humans subjects, three metabolites of nan- 256. In retrospect, this signal may have been drolone can be isolated and measured in the urine caused by interference of other endogenous com- by gas chromatography-mass spectrometry. These pounds (noise) and perhaps represents a false metabolites have been identified as 19- positive finding. The authors acknowledged the norandrosterone (NA; 3α-hydroxy-5α-oestran- limitations of the study, the analytical technique 17-one), 19-noretiocholanolone (3α-hydroxy-5β- lacking specificity and sensitivity. oestran-17-one), and 19-norepiandrosterone Studies in 1988 and 1990 again raised the (3β-hydroxy-5α-oestran-17-one).8–13 These me- possibility of endogenous NA in the urine of 21 tabolites are isomeric compounds, having the humans. Kicman and Brooks used radioimmu- same chemical composition and molecular mass noassay and measured NA in the urine of men but different chemical structure. NA is usually the and women, who were supposedly free of most abundant urine metabolite of exogenous nandrolone, ranging from 3.8 to 49.4 nandrolone.9–13 The presence of these metabolites ng/ml. However, these data should be interpreted in the urine forms the basis of doping analysis for with caution as it could be argued that the the illegal use of nandrolone by athletes.8 12 14–16 analytical technique again lacks both specificity 11 This was based on the premise that these urine and sensitivity. Debruyckere et al measured NA metabolites could only have been derived from in the urine of three subjects at concentrations of 11 See end of article for exogenous nandrolone. A study in 1982 appeared 9, 14, and 37 ng/ml. These results were later authors’ affiliations to have found NA, or a similar compound, in the attributed to nandrolone contaminated meat 19 22 ....................... urine of athletes who had not used nandrolone.8 which the subjects may have eaten. Correspondence to: In 1996, the IOC stated that a critical concentra- In 1996, the IOC declared that the presence of a Dr Lambert, MRC/UCT tion for nandrolone metabolites in the urine had small amount of NA in the urine was not consid- 17 Research Unit for Exercise been established. A doping offence for nan- ered to constitute a doping offence. This Science and Sports suggests that they acknowledged the possibility Medicine, PO Box 115, drolone was defined as a concentration of NA in Newlands 7925, South human urine exceeding 2 ng/ml in men and 5 Africa; mlambert@ 17 ng/ml in women. ................................................. sports.uct.ac.za Abbreviations: IOC, International Olympic Committee; Accepted NA, 19-norandrosterone; GC-C-IRMS, gas 26 February 2002 “Recently, the possibility of false positive chromatography-combustion-isotope ratio mass ....................... tests for nandrolone has been raised.” spectrometry www.bjsportmed.com 326 Kohler, Lambert A recent study by Reznik et al25 examined the sequelae of giving human chorionic gonadotrophin to 10 men. Human chorionic gonadotrophin increases serum testosterone in healthy men41–43 and stimulates the aromatase enzyme, causing a gradual increase in serum oestrogen.41 44 45 The serum testosterone and oestrogen increased in the 10 subjects after human chorionic gonadotrophin administration, and NA excretion in the urine increased by 250%. It may be concluded from this study that the increase in nandrolone biosynthesis was possibly associated with the increased aromatisation of testosterone to oestrogen. Figure 1 The androgen biosynthetic pathway and the proposed aromatisation of androgen to oestrogen with the formation of 19-norsteroid intermediates. “Factors that could increase the flux of androgen precursors through the testosterone biosynthetic pathway could theoretically increase the amount of of endogenous NA production. It can only be assumed that nandrolone produced.” this decision was reached on the basis of data collected by IOC laboratories during routine drug testing, as the scientific evi- Although the pathways proposed are theoretical, the avail- dence at the time was equivocal. In the late 1990s, analytical able evidence suggests that it is possible for the flux of andro- procedures for the detection and quantification of steroid 23 gen precursors through the testosterone biosynthetic pathway metabolites in urine had become increasingly sensitive. This to result in the production of endogenous nandrolone. There- may have accounted for an appreciable number of positive fore it can be assumed that factors that could increase the flux urine samples for NA being analysed in certain anti-doping of androgen precursors through the testosterone biosynthetic laboratories. Many of the positive samples were from partici- pathway could theoretically increase the amount of nan- pants of sports that had previously not been associated with drolone produced. anabolic steroid use.1 Further research with more sensitive equipment was undertaken to determine if NA could be pro- duced naturally by the human body. This research showed FACTORS WITH THE POTENTIAL TO AFFECT NA convincing evidence that NA was found in the urine of METABOLISM subjects free of exogenous nandrolone.1 15 18 24–28 The urine NA Genetics concentrations in these studies ranged from 0.01 to 1.79 There is a wide range of serum testosterone concentrations in ng/ml. In a study by Galan Martin et al,29 high NA concentra- men,32 suggesting large genetic interindividual and intraindi- tions in five sportspeople (4, 5, 6, 8, and 14 ng/ml) were vidual variability in sex steroid production and excretion over measured. One woman in the study, who was postmeno- a 24 hour period.46 The possibility therefore exists that there is pausal, had a NA concentration of 22 ng/ml. It could be argued a variable rate of NA excretion.1 Indeed, endogenous NA urine that these athletes had administered nandrolone.29 These excretion in a male athlete varied by 680% over a three month results are difficult to explain and perhaps further investiga- period1 and in another subject by 72% over a 24 hour period.15 tion of these subjects is necessary before a definite opinion can The enzyme complex 17β-hydroxysteroid dehydrogenase, be formed. which is responsible for converting androstenedione into tes- tosterone, and the aromatase enzyme complex, which converts testosterone into oestrogen, occur in muscle and METABOLISM OF NA fat.31 47 Therefore, it is conceivable that people with higher Aromatisation muscle and fat content may be more proficient in the produc- Metabolic pathways for the endogenous production of NA in tion of 19-norsteroid intermediates. The aromatase enzyme the human body need to be considered. Under normal complex per se can also show considerable genetic variability circumstances, testosterone is aromatised to oestrogen by the in expression and activity in certain people,48 with increased aromatase enzyme complex.30 Androstenedione, the direct activity of the aromatase enzyme producing larger amounts
Recommended publications
  • Seco-Steroids C07C)
    CPC - C07J - 2021.08 C07J STEROIDS (seco-steroids C07C) Definition statement This place covers: Compounds containing a cyclopenta[a]hydrophenanthrene skeleton (see below) or a ring structure derived therefrom: • by contraction or expansion of one ring by one or two atoms; • by contraction or expansion of two rings each by one atom; • by contraction of one ring by one atom and expansion of one ring by one atom; • by substitution of one or two carbon atoms of the cyclopenta[a]hydrophenanthrene skeleton, which are not shared by rings, by hetero atoms, in combination with the above defined contraction or expansion or not, or; • by condensation with carbocyclic or heterocyclic rings in combination with one or more of the foregoing alterations or not. Preparation of steroids including purification, separation, stabilisation or use of additives unless provided for elsewhere, as specified below. Treatment and modification of steroids provided that • the treatment is not provided for elsewhere and • the resultant product is a compound under the subclass definition. Relationships with other classification places In class C07, in the absence of an indication to the contrary, a compound is classified in the last appropriate place, i.e. in the last appropriate subclass. For example cyclopenta [a] hydrophenantrenes are classified in subclass C07J as steroids and not in subclasses C07C or C07D as carbocyclic or heterocyclic compounds. Subclass C07J is a function-oriented entry for the compounds themselves and does not cover the application or use of the compounds under the subclass definition. For classifying such information other entries in the IPC exist, for example: Subclass A01N: Preservation of bodies of humans or animals or plants or parts thereof; biocides, e.g.
    [Show full text]
  • Title 16. Crimes and Offenses Chapter 13. Controlled Substances Article 1
    TITLE 16. CRIMES AND OFFENSES CHAPTER 13. CONTROLLED SUBSTANCES ARTICLE 1. GENERAL PROVISIONS § 16-13-1. Drug related objects (a) As used in this Code section, the term: (1) "Controlled substance" shall have the same meaning as defined in Article 2 of this chapter, relating to controlled substances. For the purposes of this Code section, the term "controlled substance" shall include marijuana as defined by paragraph (16) of Code Section 16-13-21. (2) "Dangerous drug" shall have the same meaning as defined in Article 3 of this chapter, relating to dangerous drugs. (3) "Drug related object" means any machine, instrument, tool, equipment, contrivance, or device which an average person would reasonably conclude is intended to be used for one or more of the following purposes: (A) To introduce into the human body any dangerous drug or controlled substance under circumstances in violation of the laws of this state; (B) To enhance the effect on the human body of any dangerous drug or controlled substance under circumstances in violation of the laws of this state; (C) To conceal any quantity of any dangerous drug or controlled substance under circumstances in violation of the laws of this state; or (D) To test the strength, effectiveness, or purity of any dangerous drug or controlled substance under circumstances in violation of the laws of this state. (4) "Knowingly" means having general knowledge that a machine, instrument, tool, item of equipment, contrivance, or device is a drug related object or having reasonable grounds to believe that any such object is or may, to an average person, appear to be a drug related object.
    [Show full text]
  • University of Groningen Multi-Residue Analysis of Growth Promotors In
    University of Groningen Multi-residue analysis of growth promotors in food-producing animals Koole, Anneke IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 1998 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Koole, A. (1998). Multi-residue analysis of growth promotors in food-producing animals. s.n. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 25-09-2021 APPENDIX 1 OVERVIEW OF RELEVANT SUBSTANCES This appendix consists of two parts. First, substances that are relevant for the research presented in this thesis are given. For each substance CAS number (CAS), molecular weight (MW), bruto formula (formula) and if available UV maxima and alternative names are given. In addition, pKa values for the ß-agonists are listed, if they were available.
    [Show full text]
  • Pharmaceutical Appendix to the Tariff Schedule 2
    Harmonized Tariff Schedule of the United States (2006) – Supplement 1 (Rev. 1) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2006) – Supplement 1 (Rev. 1) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABACAVIR 136470-78-5 ACEXAMIC ACID 57-08-9 ABAFUNGIN 129639-79-8 ACICLOVIR 59277-89-3 ABAMECTIN 65195-55-3 ACIFRAN 72420-38-3 ABANOQUIL 90402-40-7 ACIPIMOX 51037-30-0 ABARELIX 183552-38-7 ACITAZANOLAST 114607-46-4 ABCIXIMAB 143653-53-6 ACITEMATE 101197-99-3 ABECARNIL 111841-85-1 ACITRETIN 55079-83-9 ABIRATERONE 154229-19-3 ACIVICIN 42228-92-2 ABITESARTAN 137882-98-5 ACLANTATE 39633-62-0 ABLUKAST 96566-25-5 ACLARUBICIN 57576-44-0 ABUNIDAZOLE 91017-58-2 ACLATONIUM NAPADISILATE 55077-30-0 ACADESINE 2627-69-2 ACODAZOLE 79152-85-5 ACAMPROSATE 77337-76-9 ACONIAZIDE 13410-86-1 ACAPRAZINE 55485-20-6 ACOXATRINE 748-44-7 ACARBOSE 56180-94-0 ACREOZAST 123548-56-1 ACEBROCHOL 514-50-1 ACRIDOREX 47487-22-9 ACEBURIC
    [Show full text]
  • Control Be Implemented. the First Large-Scale Systematic Olympic Games
    Br J Sports Med: first published as 10.1136/bjsm.11.4.162 on 1 December 1977. Downloaded from 162 Brit. J. Sports Med. - Vol. 1 1, No. 4, December 1977, pp. 162-169 RADIOIMMUNOASSAY OF ANABOLIC STEROIDS: AN EVALUATION OF THREE ANTISERA FOR THE DETECTION OF ANABOLIC STEROIDS IN BIOLOGICAL FLUIDS Robert DUGAL, Ph.D., Claire DUPUIS, Ph.D. and Michel J. BERTRAND, Ph.D. Centre de Recherches en Sciences de la Sante, Institut National de la Recherche Scientifique, Centre Hospitalier Louis-H. Lafontaine, Montrdal, Quebec, Canada ABSTRACT Recently developped radioimmunoassays (RIA) for the analysis of anabolic steroids and their metabolites in biological fluids were tested for cross-reactivity with other types of steroids. Results show that the degree of desirable cross-reactivity within the two classes of orally active anabolic steroids vary widely and that the antiserum for 19-Nortestosterone (the active principle of intramuscular, preparations) has a very high degree of undesirable cross- reactivity with components of oral contraceptives. Single and multiple dose studies in human volunteers demonstrate that the detection level and degree of retrospectivity are likewise variable but that the test easily detects most anabolic steroids during treatment. At the present time, the combination of the three antisera for the assay of a sample appears to be a relatively rapid and economic method for screening large numbers of samples in situations where doping control of anabolic steroids is required. The importance of utilizing physico-chemical means for identification of RIA potential positives is emphasized. INTRODUCTION (Sumner, 1974: Brooks et al, 1975) and identification procedures for a limited number of them have also been copyright.
    [Show full text]
  • United States Patent (19) 11 Patent Number: 4,585,591 Nitta Et Al
    United States Patent (19) 11 Patent Number: 4,585,591 Nitta et al. (45) Date of Patent: Apr. 29, 1986 (54) 17B-ETHYNYLSTEROIDs AND PROCESS 56) References Cited FOR PREPARNG SAME U.S. PATENT DOCUMENTS 75) Inventors: Issei Nitta, Machida; Shinichiro 3,023,206 2/1962 Burnet al. ..................... 260/239.55 Fujimori, Yokohama; Toshio Haruyama, Sagamihara; Shinya FOREIGN PATENT DOCUMENTS Inoue, Yamato, all of Japan 845441 8/1960 United Kingdom ............. 260/397.4 73 Assignee: Mitsubishi Chemical Industries, Ltd., OTHER PUBLICATIONS Tokyo, Japan L. A. van Dijck et al., "Synthesis and Reactions of 3-Methoxy-17-Hydroxy-17-Ethynyl-1,3,5(10)-Estra 21 Appl. No.: 325,026 triene', Recueil Journal of the Royal Netherlands Chemical Society, 96,7-8, Jul.-Aug., pp. 200-205 22 Filed: Nov. 25, 1981 (1977). Primary Examiner-Elbert L. Roberts 30 Foreign Application Priority Data Attorney, Agent, or Firm-Oblon, Fisher, Spivak, Dec. 10, 1980 JP Japan ................................ 55-174065 McClelland & Maier Dec. 10, 1980 JP Japan ... ... 55-174.066 Feb. 23, 1981 JP Japan .................................. 56-25307 (57) ABSTRACT Jul. 28, 1981 (JP) Japan ................................ 56-18343 This is disclosed novel intermediates, i.e. 1743-ethynyl steroids, which are useful for the preparation of corti 51) Int. Cl. .................................................. CO7J 1/00 coids such as hydrocortisone and prednisolone, and a 52 U.S. C. ............................ 260/3974; 260/397.45; process for preparing the same. 260/239.55 C, 260/397.5; 260/397.47 58) Field of Search ......................... 260/397.4, 397.45 4 Claims, No Drawings 4,585,591 1 2 17(3-ETHYNYLSTEROIDS AND PROCESS FOR -continued PREPARING SAME CECH BACKGROUND OF THE INVENTION This invention relates to a novel intermediate for use in the preparation of corticoids (adrenocortical hor mones) such as hydrocortisone, prednisolone and the MeO like.
    [Show full text]
  • Anabolic Steroids – a Problem in Popular Sports
    T + K (2002) 69 (3): 136 Anabolic steroids – a problem in popular sports Ulrich Hoffmann Institute of Pharmacology, Ernst-Moritz-Arndt University, D-17487 Greifswald, F.-Loeffler Str. 23 d e-mail : [email protected] Abstract The sportsmen self-administering androgenic-anabolic agents to improve their performance and their body shape continue to be a problem. After the opening of the East European borders a large number of compounds are offered on the black market and in fitness centres. As a consequence students and children practicing no sport use these agents. Most athletes have only a crude pharmacological knowledge regarding these drugs. Their information are derived from their own experience or experiences of other sportsmen. Therefore warnings con- cerning the efficacy and potential dangers of steroid misuse are neglected. Studies suggest that anabolic steroids are now the third most commonly offered drugs behind cannabis and amphetamines. The anabolic black market is a lucrative commercial business and its volume amounts to 70 Mill. €/year approximately. This paper will focus the attention on the common anabolic steroid misconceptions and review the adverse ef- fects and the problems connected with the use of the illicit drugs. 1. Introduction The use of performance enhancing drugs is not limited to elite athletes. Sociocultural stan- dards of beauty for males emphasize strength and muscularity. The broad-shouldered, narrow- hipped male body is idealized in Western media. Weight machines and performance enhanc- ing supplements are widely advertised in health and fitness centers [1]. The number of sportsmen in semi-professional as well as in popular sports self-administering ergogenic pharmacological agents continues to be a problem.
    [Show full text]
  • GC/C/IRMS) Als Potentielle Untersuchungsmethode Zum Nachweis Einer Illegalen Anwendung Von 19-17 Βββ-Nortestosteron in Der Ebermast
    Einsatz der Stabilisotopen-Massenspektrometrie (GC/C/IRMS) als potentielle Untersuchungsmethode zum Nachweis einer illegalen Anwendung von 19-17 βββ-Nortestosteron in der Ebermast Dissertation zur Erlangung des akademischen Doktorgrades der Naturwissenschaften an der Bergischen Universität im Fachbereich Mathematik und Naturwissenschaften Die Arbeit wurde in der Zeit vom 15. Mai 2003 bis 31.Dezember 2006 am Chemischen und Veterinäruntersuchungsamt in Freiburg angefertigt vorgelegt von Annette Mertineit-Heinz Wuppertal 2007 Diese Dissertation kann wie folgt zitiert werden: urn:nbn:de:hbz:468-20070870 [http://nbn-resolving.de/urn/resolver.pl?urn=urn%3Anbn%3Ade%3Ahbz%3A468-20070870] dem Allmächtigen Gott Das Geheimnis Gottes ist Jesus Christus, in dem alle Schätze der Weisheit und Erkenntnis verborgen sind. Die Bibel , Kolosser 2, 3 Dank Mein besonderer Dank gilt Herrn Prof. Dr. Michael Petz, der es mir ermöglichte, an der Universität Wuppertal diese Dissertation anzufertigen. Für seine Hilfsbereitschaft und Ermutigungen bin ich ihm sehr dankbar. Bedanken möchte ich mich beim Amtsleiter des CVUA Herrn Dr. Roland Renner sowie Laborleiter Herrn Dr. Martin Metschies, dass ich die Untersuchungen für diese Arbeit am CVUA durchführen durfte. Bei Laborleiterin Frau Dr. Eva Annweiler möchte ich mich für ihre vielseitige Unterstützung in analytischen Fragen und ihre Hilfe bei der Durchsicht der Arbeit bedanken. Den Labormitarbeitern Herrn Thomas Huber danke ich für die Unterstützung bei den EA/IRMS-Messungen, Frau Sylvia Scanlan-Sierra bei den GC/MS-Messung und Herrn Manfred Grosse bei den GC/FID-Messungen. Herr Grosse hat sich immer Zeit genommen, mich zu unterstützen, ohne dabei seine tägliche Arbeit zu vernach- lässigen. Für die Unterstützung der Aufarbeitung der Eberurine gilt mein Dank Laborleiter Herr Lippold und den Mitarbeitern Frau Annabarbara Fies, Herrn Markus Roth und Frau Maria Schmidt.
    [Show full text]
  • United States Patent Office Patented Jan
    3,231,567 United States Patent Office Patented Jan. 25, 1966 2 droxy ethylene, hydroxy propylene, hydroxybutylene and 3,231,567 PROCESS FOR THE PREPARATION OF 3-HY the like; a saturated or unsaturated cycloaliphatic moiety, DROXY. AND 3-ALKOXY-ESTRATRIENES such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, AND INTERMEDIATES THEREFOR cyclopentenyl, cyclohexenyl, cyclopentylpropyl, cyclo Alberto Ercoli and Rinaldo Gardi, Milan, and Cesare 5 heptyl, cyclooctyl radical; or an araliphatic moiety, such Pedrai, Bergamo, Italy, assignors to Francesco Wismara as benzyl, phenetyl, cynnamyl radical. Preferred hydro S.p.A., Casadenovo, Italy carbon radicals are aliphatic moieties containing from 1 No Drawing. Fied Dec. 16, 1963, Ser. No. 330,584 to 8 carbon atoms, inclusive, cycloaliphatic moieties con Claims priority, application Italy, Dec. 19, 1962, taining from 5 to 6 carbon atoms in the ring and the Patent 24,856/62 benzyl radical. 20 Claims. (C. 260-239.55) 10 Methods for the aromatization of the ring A of 19-nor This invention relates to an improved process for con steroids are already known in the literature and the prior verting steroids of the 19-nor-androstane and 19-nor-preg art teaches the conversion of a 3-keto-19-norsteroid of name series into derivatives of the estrogenic series. The the androstane series into a derivative of the estrogenic invention also relates to certain new 19-norsteroid deriva 5 series. This conversion may be accomplished by first tives useful as intermediates in said conversion. preparing a 5,10-epoxy-estren-3-one or a 3-ketal thereof More particularly, this invention is concerned with a by epoxiding a 5 (10)-estrene-3-one or A-3-keto-19-nor amethod for the aromatization of the ring A to produce steroid 3-ketal, respectively, with a peracid.
    [Show full text]
  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
    20558 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DEPARMENT OF THE TREASURY Services, U.S. Customs Service, 1301 TABLE 1.ÐPHARMACEUTICAL APPEN- Constitution Avenue NW, Washington, DIX TO THE HTSUSÐContinued Customs Service D.C. 20229 at (202) 927±1060. CAS No. Pharmaceutical [T.D. 95±33] Dated: April 14, 1995. 52±78±8 ..................... NORETHANDROLONE. A. W. Tennant, 52±86±8 ..................... HALOPERIDOL. Pharmaceutical Tables 1 and 3 of the Director, Office of Laboratories and Scientific 52±88±0 ..................... ATROPINE METHONITRATE. HTSUS 52±90±4 ..................... CYSTEINE. Services. 53±03±2 ..................... PREDNISONE. 53±06±5 ..................... CORTISONE. AGENCY: Customs Service, Department TABLE 1.ÐPHARMACEUTICAL 53±10±1 ..................... HYDROXYDIONE SODIUM SUCCI- of the Treasury. NATE. APPENDIX TO THE HTSUS 53±16±7 ..................... ESTRONE. ACTION: Listing of the products found in 53±18±9 ..................... BIETASERPINE. Table 1 and Table 3 of the CAS No. Pharmaceutical 53±19±0 ..................... MITOTANE. 53±31±6 ..................... MEDIBAZINE. Pharmaceutical Appendix to the N/A ............................. ACTAGARDIN. 53±33±8 ..................... PARAMETHASONE. Harmonized Tariff Schedule of the N/A ............................. ARDACIN. 53±34±9 ..................... FLUPREDNISOLONE. N/A ............................. BICIROMAB. 53±39±4 ..................... OXANDROLONE. United States of America in Chemical N/A ............................. CELUCLORAL. 53±43±0
    [Show full text]
  • Anabolic Steroids Detected in Bodybuilding Dietary Supplements– a Significant Risk to Public Health V
    Drug Testing 1esearch article and Analysis Received; ,. June ,01$ Revised; 1 September ,01$ <ccepted: $ September ,01$ =ublished online in 7iley Online Library 3!!!.drugtestinganalysis.com4 >%I 1..1..,?dta.17,@ Anabolic steroids detected in bodybuilding dietary supplements– a significant risk to public health V. Abbate,a A. T. Kicman,b M. Evans-Brown,c J. McVeigh,d D. A. #owan,b #. Wilson,e S. J. #olese and C. J. $alkerb& Twenty-four products suspected of containing anabolic steroids and sold in fitness equipment shops in the (nited Kingdom )(K) ere analyzed for their qualitative and semi-quantitative content using full scan gas chromatography-mass spectrometry ),#-M%*, accurate mass li'uid chromatography-mass spectrometry )-#-M%*, high pressure liquid chromatography ith diode array detection )./-#-"A"*, (V-Vis, and nuclear magnetic resonance )0M1* spectroscopy. 2n addition, 3-ray crystallography enabled the identification of one of the compounds, here reference standard as not available. 4f the 56 products tested, 57 contained steroids including kno n anabolic agents8 9: of these contained steroids that ere different to those indicated on the packaging and one product contained no steroid at all. 4verall, 97 different steroids ere identified8 95 of these are controlled in the (K under the Misuse of "rugs Act 9;<9. %everal of the products contained steroids that may be considered to have considerable pharmaco- logical activity, based on their chemical structures and the amounts present. This could un ittingly e=pose users to a significant risk to their health, hich is of particular concern for na>ve users. #opyright ? 5@96 !ohn $iley A %ons, -td.
    [Show full text]
  • Planar Chromatography of Steroid Hormones and Anabolics Meliha Leki},A* Fehim Kora},A Miroslav Šober,B Aleksandra Marjanovi}B
    88 Acta Chim. Slov. 2007, 54, 88–91 Short communication Planar Chromatography of Steroid Hormones and Anabolics Meliha Leki},a* Fehim Kora},a Miroslav Šober,b Aleksandra Marjanovi}b a University of Sarajevo, Faculty of Medicine, Sarajevo, Bosnia and Herzegovina. E-mail: [email protected]. b University of Sarajevo, Faculty of Pharmacy, Sarajevo, Bosnia and Herzegovina Received: 28-09-2006 Paper based on a presentation at the 12th International Symposium on Separation Sciences, Lipica, Slovenia, September 27–29, 2006. Abstract Simultaneous separation of eleven steroid hormones and synthetic anabolics: progesterone, trenbolone acetate, melen- gestrol acetate, 17-ß-estradiol, 19-nortestosterone, fluoxymesterone, norethandrolone, 4-chloro-δ-1-methyl testostero- ne, clostebol acetate, 6-ß-hydroxymethandienone and oxymetholone, was performed on HPTLC plates, 10 × 10 cm, si- licagel 60 F254 (Merck) by horizontal elution in chloroform-acetone mobile phase. The investigated steroids were suc- cessfully visualised under UV light (254 nm), and after spraying with an ethanolic solution of p-toluenesulphonic acid. The efficacy of chromatographic system was checked using simulated real samples for some of the examined steroids, melengestrol acetate and trenbolone acetate, usually misused as growth promoters in cattle and stored unchanged in ani- mal tissue. Keywords: steroid hormones, steroid anabolics, HPTLC 1. Introduction 2. Experimental The misuse of steroid hormones and anabolics is no- The main aim of this work was to determine optimal wadays present not only in humans (doping in sport), but conditions for efficient simultaneous separation and de- also in animals. The use of steroid hormones and anabo- tection of steroid hormones and synthetic steroid anabo- lics has been banned in the European Union since Fe- lics by means of planar chromatography.
    [Show full text]